3
Announcements
Trials
Browse
Landscape
Status
Completed
3
Sponsor Class
OTHER
3
Study Type
Observational
3
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
3
Conditions
Breast Neoplasms
6
Neoplasms
3
Prostatic Neoplasms
2
Osteoporosis
2
Smoldering Multiple Myeloma
1
Regional Osteoporosis as a Result of Chemotherapy
1
Primary Ovarian Insufficiency
1
Pain
1
Oropharyngeal Neoplasms
1
Neoplasms, Plasma Cell
1
Monoclonal Gammopathy of Undetermined Significance
1
Melanoma
1
Lymphedema
1
Esophageal Neoplasms
1
Depression
1
Cognitive Dysfunction
1
Clinical Stage III Cutaneous Melanoma AJCC v8
1
Cicatrix
1
Cardiovascular Diseases
1
Bone Mineral Density
1
Anxiety Disorders
1
Adenocarcinoma Of Esophagus
1
Interventions
Surveys and Questionnaires
86
Blood Specimen Collection
58
Interviews as Topic
28
Observation
15
Data Collection
15
Radiotherapy
12
Watchful Waiting
11
Magnetic Resonance Spectroscopy
11
Hematologic Tests
11
Exercise
11
Drug Therapy
11
Quality of Life
9
Biopsy
8
Specimen Handling
7
Therapeutics
6
Restraint, Physical
6
Magnetic Resonance Imaging
6
Focus Groups
6
pembrolizumab
5
Standard of Care
5
Rivaroxaban
5
Phlebotomy
5
Nivolumab
5
Lapatinib
5
Immune Checkpoint Inhibitors
5
atezolizumab
4
apixaban
4
Trastuzumab
4
Patient Reported Outcome Measures
4
Palliative Care
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Neoplasms
×
Absorptiometry, Photon
×
Clear all
NCT03690401
2024-10-28
PostSOZO
Prisma Health-Upstate
Completed
52 enrolled
NCT03784911
2024-10-28
DuringSOZO
Prisma Health-Upstate
Completed
51 enrolled
NCT02806154
2023-07-19
FRACTION
University Hospital, Toulouse
Completed
144 enrolled